than others. Antibacterial investigation exhibited good to excellent activity for all these compounds against two tested bacterial strains (S. aureus and E. coli). Moreover, molecular docking studies were carried out, which was consistent with experimental studies. The results motivate us for further studies of imidazole derivatives which will be helpful for the development of novel antibacterial agents
在目前的工作中,我们已经报道了一些
咪唑(MI
PBD,CMIBP,MIB
PBD)衍
生物的理论和
生物学活性。在此,也已经报道了一种新颖的取代的
咪唑基-
氨基吡啶基衍
生物(MI
PBD)的合成。该化合物的结构通过NMR和质谱鉴定。分子模型研究证实,CMIBP(ΔE= 0.16508 eV)比其他方法更稳定。对于所有这些化合物,抗菌研究均显示出对两种测试细菌菌株(
金黄色葡萄球菌和大肠杆菌)的良好至优异的活性。此外,进行了分子对接研究,这与实验研究一致。该结果激励我们进一步研究
咪唑衍
生物,这将有助于开发新型抗菌剂。